1. Successful discontinuation of immune suppression after hematopoietic cell transplantation may be less likely in the setting of peripheral blood ...
1. After transplant, graft-versus-host disease (GVHD) was more likely when the recipient had a high-expression allele and the donor ...
1. Patients with chronic graft-vs-host disease (CGVHD) after allogeneic hematopoietic stem cell transplantation (AHSCT) were more likely to develop cutaneous ...
Image: PD AML 1. Rituximab use is linked with a reduction in chronic graft-vs-host disease following peripheral blood stem cell ...
Image: PD 1. Patients with high suppressor of tumorigenicity 2 (ST2) levels at the initiation of graft-vs-host-disease (GVHD) therapy were ...
Image: PD 1. The genome of a novel bacterium Bradyrhizobium enterica was discovered via gene sequencing in patients with cord ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.